| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $1.41 (Miss by $-0.41) |
| EPS GAAP Actual | $1.41 (Miss by $-0.41) |
| Revenue Actual | $3.9738B |
| Revenue Surprise | Beat by $3973.8M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.37 |
| EPS GAAP Estimate | $1.37 |
| Revenue Estimate | $3.4303B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.36 | -0.16836 | 3.9738B | 12.14% | 114.53M |
| FQ2 2025 (Jun 2025) | -1.34 | -2.87 | 3.6572B | 5.58% | -202.07M |
| FQ1 2025 (Mar 2025) | 2.09 | 0.75 | 3.6513B | 7.32% | 39.1M |
| FQ4 2024 (Dec 2024) | 1.72 | 0.22961 | 3.8958B | 7.98% | 242.6M |
| FQ3 2024 (Sep 2024) | 2.18 | 0.62421 | 3.4915B | -4.35% | -180.8M |
| FQ2 2024 (Jun 2024) | 1.21 | -0.13259 | 3.453B | -5.79% | -2923.13M |
| FQ1 2024 (Mar 2024) | 1.24 | 1.24 | 3.384B | -3.17% | 3384M |
| FQ4 2023 (Dec 2023) | 1.11 | 1.11 | 3.5849B | 7.57% | 3584.9M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.37
Consensus Revenue Estimates
3.4303B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 2.13 | -- | 2.06222 | 2.27014 | 3 |
| FQ3 2026 (Sep 2026) | 1.84 | 26.09 | 1.78145 | 1.96106 | 3 |
| FQ2 2026 (Jun 2026) | 1.44 | 193.06 | 1.39418 | 1.53474 | 3 |
| FQ1 2026 (Mar 2026) | 1.37 | -52.55 | 1.32641 | 1.46014 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 3.65B | -- | 3.56B | 3.83B | 4 |
| FQ3 2026 (Sep 2026) | 3.76B | -5.55 | 3.67B | 3.96B | 4 |
| FQ2 2026 (Jun 2026) | 3.59B | -1.89 | 3.5B | 3.77B | 4 |
| FQ1 2026 (Mar 2026) | 3.43B | -6.44 | 3.35B | 3.6B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.52836 | 1.36 | -0.16836 | -12.38% |
| FQ2 2025 (Jun 2025) | 1.53 | -1.34 | -2.87 | 214.18% |
| FQ1 2025 (Mar 2025) | 1.34 | 2.09 | 0.75 | 35.89% |
| FQ4 2024 (Dec 2024) | 1.49039 | 1.72 | 0.22961 | 13.35% |
| FQ3 2024 (Sep 2024) | 1.55579 | 2.18 | 0.62421 | 28.63% |
| FQ2 2024 (Jun 2024) | 1.34259 | 1.21 | -0.13259 | -10.96% |
| FQ1 2024 (Mar 2024) | 1.24 | 1.24 | 100% | |
| FQ4 2023 (Dec 2023) | 1.11 | 1.11 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.86B | $3.97B | $114.53M | 2.88% |
| FQ2 2025 (Jun 2025) | $3.86B | $3.66B | $-202.07M | -5.53% |
| FQ1 2025 (Mar 2025) | $3.61B | $3.65B | $39.1M | 1.07% |
| FQ4 2024 (Dec 2024) | $3.65B | $3.9B | $242.6M | 6.23% |
| FQ3 2024 (Sep 2024) | $3.67B | $3.49B | $-180.8M | -5.18% |
| FQ2 2024 (Jun 2024) | $6.38B | $3.45B | $-2923.13M | -84.65% |
| FQ1 2024 (Mar 2024) | $0B | $3.38B | $3384M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.58B | $3584.9M | 100% |